Acupuncture for patients with mild hypertension: A randomized controlled trial.
Hui ZhengJuan LiYing LiLing ZhaoXi WuJie ChenXiang LiYin-Lan HuangXiao-Rong ChangMi LiuJin CuiRui-Hui WangXu DuJing ShiTai-Pin GuoFan-Rong LiangPublished in: Journal of clinical hypertension (Greenwich, Conn.) (2019)
Acupuncture may be beneficial for patients with mild hypertension, but the evidence is not convincing. We aimed to examine the effect of acupuncture on blood pressure (BP) reduction in patients with mild hypertension. We conducted a multicenter, single-blind, sham-controlled, randomized trial in eleven hospitals in China. The trial included 428 patients with systolic blood pressure (SBP) from 140 to 159 mm Hg and/or with diastolic blood pressure (DBP) from 90 to 99 mm Hg. The patients were randomly assigned to receive 18 sessions of affected meridian acupuncture (n = 107) or non-affected meridian acupuncture (n = 107) or sham acupuncture (n = 107) during 6 weeks, or to stay in a waiting-list control (n = 107). All patients received 24-hour ambulatory blood pressure monitoring at weeks 6, 9, and 12. We included 415 participants in the intention-to-treat analysis. The two acupuncture groups were pooled in the analysis, since they had no difference in all outcomes. SBP decreased at week 6 in acupuncture group vs sham acupuncture vs waiting-list group (7.2 ± 11.0 mm Hg vs 4.1 ± 11.5 mm Hg vs 4.1 ± 13.2 mm Hg); acupuncture was not superior to sham acupuncture (mean difference 2.7 mm Hg, 95% CI 0.4 to 5.9, adjusted P = 0.103) or waiting-list control (2.9 mm Hg, 95% CI -0.2 to 6.0, adjusted P = 0.078). However, acupuncture was superior to sham acupuncture (3.3 mm Hg, 95% CI 0.2 to 6.3, adjusted P = 0.035) and waiting-list control (4.8 mm Hg, 95% CI 1.8 to 7.8, P < 0.001) at week 9. Acupuncture had a small effect size on the reduction of BP in patients with mild hypertension.
Keyphrases
- blood pressure
- hypertensive patients
- heart rate
- fluorescent probe
- end stage renal disease
- ejection fraction
- chronic kidney disease
- randomized controlled trial
- heart failure
- metabolic syndrome
- type diabetes
- living cells
- healthcare
- left ventricular
- prognostic factors
- peritoneal dialysis
- insulin resistance
- atrial fibrillation
- study protocol
- cross sectional
- gestational age